Rare diseases
Investigational molecules
Locations
Back to Greece978 clinical trials in Athens, Greece across 13 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer
GreeceStudy on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis
GreeceStudy Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency
GreeceStudy of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer
GreeceStudy on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus
GreeceGreeceStudy on Carfilzomib and Ibrutinib for Patients with Waldenström’s Macroglobulinemia
GreeceStudy of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments
GreeceStudy on Iberdomide for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem Cell Transplantation
GreeceStudy of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy
GreeceStudy Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
GreeceStudy of isatuximab, belantamab mafodotin and dexamethasone combination for patients with relapsed or refractory multiple myeloma
GreeceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on head and neck cancer, bladder cancer, and advanced solid tumors. Research includes innovative combination therapies and novel treatment approaches for various tumor types.
Studies evaluate new therapeutic combinations and their impact on patient survival rates.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome, lupus, and inflammatory conditions.
Focus on developing targeted therapies for chronic autoimmune conditions.
Research examining treatments for heart failure, cardiovascular disease prevention, and metabolic disorders including obesity.
Trials evaluating new therapeutic approaches for cardiovascular risk reduction.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
